XT
ALLR

XTX Topco’s Allarity Therapeutics ALLR Stock Holding History

XTX Topco’s Portfolio ALLR Stock Details ALLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.9K Sell
20,884
-8,083
-28% -$11.5K ﹤0.01% 3850
2026
Q1 		$31.6K Sell
28,967
-4,677
-14% -$5.03K ﹤0.01% 3442
2025
Q4 		$36.3K Buy
+33,644
New +$42.9K ﹤0.01% 2911
2025
Q3 		– Sell
-50,950
Closed -$51.5K – 2516
2025
Q2 		$51.5K Buy
+50,950
New +$48.2K ﹤0.01% 2009

Other funds holding ALLR

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

XTX Topco's ALLR Position: Q2 2026 in Review

XTX Topco reduced its Allarity Therapeutics (ALLR) stake by 28% in Q2 2026, selling an estimated $11.5K and leaving 20,884 shares worth $26.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3850.

XTX Topco first reported a position in ALLR in Q2 2025 and has held it in 4 quarters since. The position peaked at $51.5K in Q2 2025. 20 funds tracked by Wall St. Rank hold ALLR as of Q2 2026.

  • XTX Topco held 20,884 shares of Allarity Therapeutics worth $26.9K as of Q2 2026.
  • XTX Topco sold 8,083 Allarity Therapeutics shares in Q2 2026, an estimated $11.5K.
  • Allarity Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3850 holding.
  • XTX Topco first reported a position in Allarity Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • XTX Topco's Allarity Therapeutics position peaked at $51.5K in Q2 2025.
  • 20 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.